Nicoya's Series A Extension is led by Whitecap Venture Partners, with participation from industry leader Agilent Technologies Inc (NYSE: A) Nicoya Lifesciences, a global leader in digital proteomics
Felix Health raises $10 million amid increased demand for virtual prescription service focused on stigmatized health issues
Toronto-based healthtech startup Felix Health, which offers users access to treatments for common, but often stigmatized, health issues, has raised a $10 million CAD Series A round of funding.
The round was led by new investor Whitecap Ventures. Previous investors Mantella Venture Partners, BrandProject and H Ventures also participated in the round. Following the deal, which closed in late December, Russell Samuels, partner at Whitecap Venture Partners, has joined Felix Health’s board of directors.
“COVID accelerated the interest in giving virtual healthcare a try for people that were either on the fence or maybe hadn’t done it before.”